{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:34:37Z","timestamp":1790048077583,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Contactless harm reduction supply methods (e.g., vending machines, mail order, mobile delivery) have become prevalent in the United States. However, this approach has faced some criticisms, including the notion that, unlike staffed syringe services programs, contactless methods do not provide face-to-face support, education, or referrals to treatment, potentially limiting their overall impact.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We collected self-reported data from a sample of people who inject drugs who accessed a syringe services program (N\u2009=\u200950), including their demographics, harm reduction self-efficacy (i.e., confidence to employ specific health-preserving coping skills in high-risk drug using situations), and motivations for contactless harm reduction supply access via vending machine. We explored differences in the participants' demographics and harm reduction self-efficacy by usual method of harm reduction supply access (in-person vs. vending machine).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Participants accessed the harm reduction supply vending machine primarily out of convenience (66%) and limited syringe services program hours (56%). Fear of being seen by someone they knew (28%), law enforcement (34%), and social services (22%) were also motivators. Overall, harm reduction self-efficacy was highest for safer injection practices but lowest for reducing drug use. We did not find any significant differences in participants\u2019 demographics or harm reduction self-efficacy by access method.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>People who access harm reduction supplies in person and through contactless methods may not meaningfully differ in terms of their demographics and harm reduction self-efficacy, and contactless harm reduction supply methods are more convenient than in-person services. Findings support continued reductions to barriers of harm reduction services.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12954-025-01288-8","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T08:20:40Z","timestamp":1753690840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Harm reduction self-efficacy and motivations for contactless supply access among a sample of syringe services program participants"],"prefix":"10.1186","volume":"22","author":[{"given":"Rachel A.","family":"Hoopsick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Andrew","family":"Yockey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"1288_CR1","volume-title":"Self-efficacy: the exercise of control","author":"A Bandura","year":"1997","unstructured":"Bandura A. Self-efficacy: the exercise of control. New York: Macmillan; 1997."},{"key":"1288_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2024.116683","volume":"345","author":"G Bardwell","year":"2024","unstructured":"Bardwell G, Ivsins A, Wallace JR, Mansoor M, Kerr T. \u201cThe machine doesn\u2019t judge\u201d: counternarratives on surveillance among people accessing a safer opioid supply via biometric machines. Soc Sci Med. 2024;345: 116683.","journal-title":"Soc Sci Med"},{"key":"1288_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.drugalcdep.2015.02.011","volume":"149","author":"RN Bluthenthal","year":"2015","unstructured":"Bluthenthal RN, Wenger L, Chu D, Lorvick J, Quinn B, Thing JP, Kral AH. Factors associated with being asked to initiate someone into injection drug use. Drug Alcohol Depend. 2015;149:252\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"1288_CR4","unstructured":"Bonn, M. (2020). Canada\u2019s safe supply vending machine project is even more important now. Filter. In."},{"issue":"1","key":"1288_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.japh.2022.12.017","volume":"63","author":"JP Bratberg","year":"2023","unstructured":"Bratberg JP, Simmons A, Arya V, Bhatia A, Vakharia SP. Support, don\u2019t punish: drug decriminalization is harm reduction. J Am Pharm Assoc. 2023;63(1):224\u20139.","journal-title":"J Am Pharm Assoc"},{"issue":"Suppl 1","key":"1288_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/1468-0009.12602","volume":"101","author":"M Cerd\u00e1","year":"2023","unstructured":"Cerd\u00e1 M, Krawczyk N, Keyes K. The future of the United States overdose crisis: challenges and opportunities. Milbank Q. 2023;101(Suppl 1):478.","journal-title":"Milbank Q"},{"issue":"1","key":"1288_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12954-020-00370-7","volume":"17","author":"A Dunlop","year":"2020","unstructured":"Dunlop A, Lokuge B, Masters D, Sequeira M, Saul P, Dunlop G, Ryan J, Hall M, Ezard N, Haber P. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduct J. 2020;17(1):26.","journal-title":"Harm Reduct J"},{"issue":"1_suppl","key":"1288_CR8","doi-asserted-by":"publisher","first-page":"128s","DOI":"10.1177\/0033354920921817","volume":"135","author":"MH Fern\u00e1ndez-Vi\u00f1a","year":"2020","unstructured":"Fern\u00e1ndez-Vi\u00f1a MH, Prood NE, Herpolsheimer A, Waimberg J, Burris S. State laws governing syringe services programs and participant syringe possession, 2014\u20132019. Public Health Rep. 2020;135(1_suppl):128s\u201337s. https:\/\/doi.org\/10.1177\/0033354920921817.","journal-title":"Public Health Rep"},{"key":"1288_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s11524-021-00534-1","volume":"98","author":"BT Hayes","year":"2021","unstructured":"Hayes BT, Favaro J, Davis CS, Gonsalves GS, Beletsky L, Vlahov D, Heimer R, Fox AD. Harm reduction, by mail: the next step in promoting the health of people who use drugs. J Urban Health. 2021;98:532\u20137.","journal-title":"J Urban Health"},{"key":"1288_CR10","doi-asserted-by":"crossref","unstructured":"Herrera, A. (2025). Advancing Equitable Access to Harm Reduction: Implementation and Early Use of an Outdoor Harm Reduction Vending Machine, Kern County, California, 2023. Public Health Reports\u00ae, 00333549241308169.","DOI":"10.1177\/00333549241308169"},{"key":"1288_CR11","unstructured":"Illinois Department of Public Health. (2025). Illinois counties: mortality| morbidity. https:\/\/dph.illinois.gov\/topics-services\/opioids\/idph-data-dashboard\/overdoses.html"},{"key":"1288_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7517-4-14","volume":"4","author":"MM Islam","year":"2007","unstructured":"Islam MM, Conigrave KM. Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review. Harm Reduct J. 2007;4:1\u20139.","journal-title":"Harm Reduct J"},{"issue":"6","key":"1288_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.drugpo.2007.07.006","volume":"19","author":"MM Islam","year":"2008","unstructured":"Islam MM, Wodak A, Conigrave KM. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings. Int J Drug Policy. 2008;19(6):436\u201341.","journal-title":"Int J Drug Policy"},{"key":"1288_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.drugpo.2018.04.006","volume":"57","author":"A Ivsins","year":"2018","unstructured":"Ivsins A, Marsh S. Exploring what shapes injection and non-injection among a sample of marginalized people who use drugs. Int J Drug Policy. 2018;57:72\u20138.","journal-title":"Int J Drug Policy"},{"issue":"9","key":"1288_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0309938","volume":"19","author":"D Kline","year":"2024","unstructured":"Kline D, Hepler SA, Krawczyk N, Rivera-Aguirre A, Waller LA, Cerd\u00e1 M. A state-level history of opioid overdose deaths in the United States: 1999\u20132021. PLoS ONE. 2024;19(9): e0309938.","journal-title":"PLoS ONE"},{"issue":"1","key":"1288_CR16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.clinpsy.121208.131438","volume":"6","author":"GA Marlatt","year":"2010","unstructured":"Marlatt GA, Witkiewitz K. Update on harm-reduction policy and intervention research. Annu Rev Clin Psychol. 2010;6(1):591\u2013606.","journal-title":"Annu Rev Clin Psychol"},{"key":"1288_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.111053","volume":"255","author":"CE Megerian","year":"2024","unstructured":"Megerian CE, Bair L, Smith J, Browne EN, Wenger LD, Guzman L, Kral AH, Lambdin BH. Health risks associated with smoking versus injecting fentanyl among people who use drugs in California. Drug Alcohol Depend. 2024;255: 111053.","journal-title":"Drug Alcohol Depend"},{"key":"1288_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100271","author":"K Milaney","year":"2022","unstructured":"Milaney K, Haines-Saah R, Farkas B, Egunsola O, Mastikhina L, Brown S, Lorenzetti D, Hansen B, McBrien K, Rittenbach K. A scoping review of opioid harm reduction interventions for equity-deserving populations. Lancet Regional Health Am. 2022. https:\/\/doi.org\/10.1016\/j.lana.2022.100271.","journal-title":"Lancet Regional Health Am"},{"key":"1288_CR19","unstructured":"North American Syringe Exchange Network. NASEN directory of syringe service programs. Retrieved 3 Jul 2025 from https:\/\/nasen.org\/"},{"issue":"1","key":"1288_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1037\/0893-164X.22.1.36","volume":"22","author":"KT Phillips","year":"2008","unstructured":"Phillips KT, Rosenberg H. The development and evaluation of the harm reduction self-efficacy questionnaire. Psychol Addict Behav. 2008;22(1):36.","journal-title":"Psychol Addict Behav"},{"issue":"1","key":"1288_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12954-023-00765-2","volume":"20","author":"E Russell","year":"2023","unstructured":"Russell E, Johnson J, Kosinski Z, Kaplan C, Barnes N, Allen S, Haroz E. A scoping review of implementation considerations for harm reduction vending machines. Harm Reduct J. 2023;20(1):33.","journal-title":"Harm Reduct J"},{"key":"1288_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/PHH.0000000000002128","author":"LC Shaw","year":"2025","unstructured":"Shaw LC, Brown EA, Creegan E, Bertrand TE, Ogundare S, Park CJ, Berk J, Chan PA, Marshall BD. Comparing harm reduction vending machines and in-person overdose prevention services in practice: a case study from Rhode Island. J Public Health Manag Pract. 2025. https:\/\/doi.org\/10.1097\/PHH.0000000000002128.","journal-title":"J Public Health Manag Pract"},{"issue":"1","key":"1288_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12954-023-00747-4","volume":"20","author":"RE Stewart","year":"2023","unstructured":"Stewart RE, Cardamone NC, Loscalzo E, French R, Lovelace C, Mowenn WK, Tarhini A, Lalley-Chareczko L, Brady KA, Mandell DS. \u201cThere\u2019s absolutely no downside to this, I mean, except community opposition:\u201d A qualitative study of the acceptability of vending machines for harm reduction. Harm Reduct J. 2023;20(1):25.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1288_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12954-024-01038-2","volume":"21","author":"R Sun","year":"2024","unstructured":"Sun R, Sauda TH, Hoopsick RA. Unmet needs and harm reduction preferences of syringe services program participants: differences by co-use of illicit opioids and methamphetamine. Harm Reduct J. 2024;21(1):119. https:\/\/doi.org\/10.1186\/s12954-024-01038-2.","journal-title":"Harm Reduct J"},{"key":"1288_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102880","volume":"83","author":"M Tyndall","year":"2020","unstructured":"Tyndall M. Safer opioid distribution in response to the COVID-19 pandemic. Int J Drug Policy. 2020;83: 102880.","journal-title":"Int J Drug Policy"},{"key":"1288_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2022.100094","volume":"5","author":"NM Wagner","year":"2022","unstructured":"Wagner NM, Kempe A, Barnard JG, Rinehart DJ, Havranek EP, Glasgow RE, Blum J, Morris MA. Qualitative exploration of public health vending machines in young adults who misuse opioids: a promising strategy to increase naloxone access in a high risk underserved population. Drug Alcohol Depend Reports. 2022;5: 100094.","journal-title":"Drug Alcohol Depend Reports"},{"key":"1288_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2025.104709","volume":"137","author":"AM Young","year":"2025","unstructured":"Young AM, Jahangir T, Belton I, Freeman E, Livingston MD. Likelihood of using a harm reduction vending machine among rural people who inject drugs in Appalachian Kentucky. Int J Drug Policy. 2025;137: 104709.","journal-title":"Int J Drug Policy"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01288-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01288-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01288-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T03:47:50Z","timestamp":1757303270000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01288-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1288"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01288-8","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}